Skip to main content

Ventyx Biosciences, Inc.

VTYXDelisted Mar 4, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001851194

Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ventyx Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ventyx Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ventyx Biosciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Subramaniam SomuDirector0IndirectMar 4, 20262
Hulme AllisonDirector–Mar 4, 20261
Gujrathi SheilaDirector0IndirectMar 4, 20261
White William RichardDirector0Mar 4, 20261
Cadoret-Manier OnaizaDirector–Mar 4, 20261
Moore Matthew RichardChief Operating Officer–Mar 4, 20261
Nuss JohnCHIEF SCIENTIFIC OFFICER0Mar 4, 20262
Mohan RajuCEO AND PRESIDENT0Mar 4, 20262
Forman Mark SChief Medical Officer0Mar 4, 20262
Gonzales RoySenior VP, Finance0Mar 4, 20262
NSV Partners III GP LLC10% Owner7,102,969IndirectJun 26, 20240
NSV Partners III LP10% Owner7,102,969IndirectJun 26, 20240
Krueger Christopher WCHIEF BUSINESS OFFICER284,999Apr 3, 20240
Auster MartinCHIEF FINANCIAL OFFICER24,303Apr 3, 20240
Sandborn William J.See Remarks48,389Sep 1, 20230
Royston AaronDirector3,997,269IndirectApr 26, 20230
NSV Investments I, L.P.10% Owner13,274,786IndirectDec 15, 20220
Choksey JigarDirector–Jul 1, 20220
Goodman Corey S10% Owner3,997,269Jun 10, 20220
Adelman Robert J10% Owner3,997,269Jun 10, 20220
venBio Global Strategic Fund III, L.P.10% Owner, Other: See Remarks3,997,269Jun 10, 20220
Venbio Global Strategic GP III, Ltd10% Owner3,997,269Jun 10, 20220
Venbio Global Strategic GP III, L.P.10% Owner3,997,269Jun 10, 20220
Gaster RichardDirector–Jun 10, 20220
Drappa JornChief Medical Officer–Feb 4, 20220
Cormorant Asset Management, LPOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Chen BihuaOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Cormorant Global Healthcare Master Fund, LPOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Cormorant Private Healthcare Fund III LP10% Owner1,410,303IndirectOct 27, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 19, 2025 (view filing)Dec 181 dayMohan RajuCEO AND PRESIDENTSSale−47.3K$7.72−$365.5K−2.0%2.37M after
Dec 19, 2025 (view filing)Dec 181 dayNuss JohnCHIEF SCIENTIFIC OFFICERSSale−12.7K$7.72−$97.9K−2.5%489.5K after
Apr 3, 2025 (view filing)Apr 21 dayNuss JohnCHIEF SCIENTIFIC OFFICERSSale−1.89K$1.07−$2.02K−0.4%467.2K after
Dec 30, 2024 (view filing)Dec 273 daysNuss JohnCHIEF SCIENTIFIC OFFICERSSale−21.1K$2.36−$49.8K−4.3%464.6K after
Dec 26, 2024 (view filing)Dec 233 daysGujrathi SheilaDirectorPPurchase+130.0K$2.31+$300.3KNew position130.0K after
Dec 19, 2024 (view filing)Dec 19Same dayNuss JohnCHIEF SCIENTIFIC OFFICERSSale−13.2K$2.26−$29.7K−2.6%485.7K after
Nov 25, 2024 (view filing)Nov 22-253 daysMohan RajuCEO AND PRESIDENTPPurchase+500.0K$1.92+$962.1K+29.9%2.18M after2 lots
Apr 3, 2024 (view filing)Apr 21 dayKrueger Christopher WCHIEF BUSINESS OFFICERSSale−1.65K$5.40−$8.92K−0.6%285.0K after
Apr 3, 2024 (view filing)Apr 21 dayNuss JohnCHIEF SCIENTIFIC OFFICERSSale−1.65K$5.40−$8.92K−0.6%265.0K after
Apr 3, 2024 (view filing)Apr 21 dayMohan RajuCEO AND PRESIDENTSSale−4.31K$5.40−$23.3K−0.3%1.58M after
Apr 3, 2024 (view filing)Apr 21 dayAuster MartinCHIEF FINANCIAL OFFICERSSale−1.41K$5.40−$7.59K−5.5%24.3K after
Dec 21, 2023 (view filing)Dec 201 dayNuss JohnChief Scientific OfficerSSale−17.6K$2.12−$37.4K−6.3%262.1K after
Dec 21, 2023 (view filing)Dec 201 dayKrueger Christopher WChief Business OfficerSSale−5.29K$2.12−$11.2K−1.8%282.1K after
Dec 21, 2023 (view filing)Dec 201 dayMohan RajuCEO and PresidentSSale−58.9K$2.12−$124.8K−3.6%1.57M after
Oct 11, 2023 (view filing)4:21 PM ETOct 92 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−49.2K$30.03−$1.48M−0.6%8.44M after
Oct 11, 2023 (view filing)Oct 92 daysSubramaniam SomuDirector, 10% OwnerSSale−49.2K$30.03−$1.48M−0.6%8.44M after
Oct 6, 2023 (view filing)Oct 51 dayMohan RajuChief Executive OfficerSSale−30.0K$29.11−$873.3K−1.9%1.51M after
Oct 4, 2023 (view filing)7:26 PM ETOct 31 dayNuss JohnChief Scientific OfficerSSale−10.0K$29.99−$299.9K−3.9%244.8K after2 lots
Oct 4, 2023 (view filing)Oct 31 dayKrueger Christopher WChief Business OfficerSSale−15.0K$29.98−$449.7K−5.1%276.5K after2 lots
Sep 20, 2023 (view filing)7:16 PM ETSep 182 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−56.7K$37.81−$2.14M−0.7%8.49M after
Sep 20, 2023 (view filing)Sep 182 daysSubramaniam SomuDirector, 10% OwnerSSale−56.7K$37.81−$2.14M−0.7%8.49M after
Sep 7, 2023 (view filing)4:21 PM ETSep 52 daysNuss JohnChief Scientific OfficerSSale−10.0K$32.60−$326.0K−3.9%244.8K after2 lots
Sep 7, 2023 (view filing)Sep 52 daysAuster MartinChief Financial OfficerSSale−26.5K$32.61−$863.4K−55.6%21.2K after3 lots
Sep 7, 2023 (view filing)Sep 52 daysKrueger Christopher WChief Business OfficerSSale−15.0K$32.61−$489.1K−5.1%276.5K after3 lots
Sep 7, 2023 (view filing)Sep 52 daysMohan RajuChief Executive OfficerSSale−30.0K$32.61−$978.4K−1.9%1.51M after3 lots
Sep 1, 2023 (view filing)Aug 311 daySandborn William J.See RemarksSSale−11.9K$33.64−$400.3K−19.7%48.4K after
Aug 8, 2023 (view filing)Aug 8Same daySandborn William J.See RemarksSSale−3.49K$32.86−$114.8K−12.6%24.2K after2 lots
Aug 8, 2023 (view filing)Aug 71 dayMohan RajuChief Executive OfficerSSale−30.0K$33.52−$1.01M−1.9%1.51M after3 lots
Aug 4, 2023 (view filing)6:08 PM ETAug 31 dayNuss JohnChief Scientific OfficerSSale−10.0K$35.60−$356.0K−3.9%244.8K after2 lots
Aug 4, 2023 (view filing)Aug 31 dayKrueger Christopher WChief Business OfficerSSale−15.0K$35.59−$533.9K−5.1%276.5K after2 lots
Aug 1, 2023 (view filing)5:43 PM ETJul 28-314 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−11.4K$37.58−$429.0K−0.1%8.55M after2 lots
Aug 1, 2023 (view filing)Jul 28-314 daysSubramaniam SomuDirector, 10% OwnerSSale−11.4K$37.59−$429.0K−0.1%8.55M after2 lots
Aug 1, 2023 (view filing)Jul 311 daySandborn William J.See RemarksSSale−11.9K$37.16−$442.2K−19.7%48.4K after
Jul 26, 2023 (view filing)Jul 251 dayAuster MartinChief Financial OfficerSSale−28.0K$35.54−$995.1K−37.0%47.6K after
Jul 19, 2023 (view filing)7:10 PM ETJul 712 daysNSV Partners III GP LLC and 1 other10% OwnerSSaleStock−75.7K$34.99−$2.65M−0.8%9.58M afterAmended
Jul 19, 2023 (view filing)7:10 PM ETJul 712 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−24.3K$35.99−$875.0K−0.3%9.55M afterAmended2 lots
Jul 19, 2023 (view filing)Jul 712 daysSubramaniam SomuDirector, 10% OwnerSSale−100.0K$35.23−$3.52M−1.0%9.55M afterAmended3 lots
Jul 13, 2023 (view filing)9:26 PM ETJul 11-122 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−31.9K$37.55−$1.20M−0.4%8.56M after2 lots
Jul 13, 2023 (view filing)Jul 11-122 daysSubramaniam SomuDirector, 10% OwnerSSale−31.9K$37.55−$1.20M−0.4%8.56M after2 lots
Jul 6, 2023 (view filing)6:25 PM ETJul 33 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−134.1K$39.00−$5.23M−1.4%9.65M after5 lots
Jul 6, 2023 (view filing)Jul 33 daysSubramaniam SomuDirector, 10% OwnerSSale−134.1K$39.00−$5.23M−1.4%9.65M after5 lots
Jul 5, 2023 (view filing)8:20 PM ETJul 32 daysNuss JohnChief Scientific OfficerSSale−20.0K$39.58−$791.6K−7.6%244.8K after6 lots
Jul 5, 2023 (view filing)8:18 PM ETJul 32 daysKrueger Christopher WChief Business OfficerSSale−15.0K$39.22−$588.3K−5.1%276.5K afterFrom original6 lots
Jul 5, 2023 (view filing)Jul 5Same dayMohan RajuChief Executive OfficerSSale−30.0K$38.37−$1.15M−1.9%1.51M after4 lots
Jul 5, 2023 (view filing)Jul 32 daysSandborn William J.See RemarksSSale−11.9K$40.00−$476.0K−19.7%48.4K after
Jul 5, 2023 (view filing)Jul 32 daysSandborn William J.See RemarksSSale−3.49K$40.00−$139.5K−11.2%27.7K after
Jun 27, 2023 (view filing)6:01 PM ETJun 234 daysSandborn William J.See RemarksSSale−10.8K$32.70−$352.8K−18.2%48.4K after2 lots
Jun 16, 2023 (view filing)7:15 PM ETJun 142 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−50.0K$35.08−$1.75M−0.5%9.79M after
Jun 16, 2023 (view filing)Jun 151 daySandborn William J.See RemarksSSale−3.49K$34.16−$119.1K−10.1%31.2K after2 lots
Jun 16, 2023 (view filing)Jun 142 daysSubramaniam SomuDirector, 10% OwnerSSale−50.0K$35.08−$1.75M−0.5%9.79M after